Elia del Medigo

CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care

Retrieved on: 
Thursday, August 17, 2023
Nursing, Health, Surgery, Health Technology, Genetics, General Health, Biotechnology, OPO, Elia del Medigo, Yale School of Medicine, Gift, Pharmacy, FAST, Education, HLA, Health equity, Medicine, Digital Solutions, Transplant, Patient, Former, OPOS, Organ, Acquisition, Laboratory, Quality, FACS, UNOS, Immunology, LIMS, Conference, Caregiver, Kidney, Dentistry, Faculty, MD

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its second annual digital health user conference, the Management Expert Exchange in Transplantation (MEET) Conference, taking place August 27-29 in Dallas, Texas.

Key Points: 
  • CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its second annual digital health user conference, the Management Expert Exchange in Transplantation (MEET) Conference, taking place August 27-29 in Dallas, Texas.
  • Transplant administrators, quality managers, transplant clinicians, and organ procurement organization (OPO) professionals will come together for this one-of-a-kind event.
  • At the conference, participants will share best practices, discuss emerging trends, and learn how to leverage the latest digital health innovations to improve transplant operations, quality improvement, patient management, and health equity.
  • “We look forward to hosting our yearly digital health conference, where thought leaders gather to share innovations as we collectively navigate the intricate tapestry of patient touchpoints in the transplant journey,” said Kashif Rathore, Chief of Patient and Digital Solutions.

CareDx Acquires MediGO, an Organ Transplant Supply Chain and Logistics Company

Retrieved on: 
Tuesday, July 25, 2023
Technology, Public Relations, Investor Relations, Communications, Health Technology, Software, General Health, Health, Data Management, Supply Chain Management, Retail, OPO, Elia del Medigo, Partnership, Innovation system, Medical school, Movement, Transplant, OPOS, Hospital, Acquisition, Medical University of South Carolina, Patient, Machine learning, Medicine, Ecosystem, Caregiver, Pharmaceutical industry, Management

"MediGO shares our patient-centric mission to improve the transplant journey and brings a wealth of expertise to CareDx.

Key Points: 
  • "MediGO shares our patient-centric mission to improve the transplant journey and brings a wealth of expertise to CareDx.
  • By leveraging our combined strengths, we will drive operational efficiencies, accelerate innovation, and deliver even greater value to the transplant ecosystem by addressing the serious organ transplant shortage," said Reg Seeto, CEO and President of CareDx.
  • CareDx and MediGO hold shared values and a mission to deliver transformational solutions that improve the transplant patient journey," said Scott Plank, Executive Chairman and Founder of MediGO.
  • MediGO 's innovative healthcare supply chain technology and software solutions have been recognized by Edison Awards and Fast Company for their disruptive technology and are powered by proprietary algorithms and machine learning.

National Kidney Foundation's Innovation Fund Invests in Klinrisk to Revolutionize Chronic Kidney Disease Care

Retrieved on: 
Monday, June 12, 2023
Partnership, Kidney failure, Therapy, Chronic kidney disease, Health equity, Quality of life, Intelligence, Strategic Innovation Fund, Dialysis, Patient, Investment, NKF, Elia del Medigo, National Kidney Foundation, Kidney, CKD, Kidney disease, Disease, Pharmaceutical industry

Klinrisk is dedicated to transforming the early identification and management of high-risk chronic kidney disease (CKD) through accurate clinical risk prediction and decision support.

Key Points: 
  • Klinrisk is dedicated to transforming the early identification and management of high-risk chronic kidney disease (CKD) through accurate clinical risk prediction and decision support.
  • The NKF's Innovation Fund, established to drive advancements in kidney health, has a track record of supporting innovative solutions that improve health equity and outcomes for kidney disease patients.
  • Klinrisk, an important addition to the NKF's Innovation Fund portfolio, has developed highly accurate, lab-based prediction models that identify high-risk CKD early.
  • "My vision has always been focused on bringing risk-based care to patients with chronic kidney disease," said Navdeep Tangri, co-founder of Klinrisk.

MediGO’s Latest Solution Digitally Transforms the Organ Recovery Process

Retrieved on: 
Tuesday, April 18, 2023
OPO, Elia del Medigo, Communication, Partnership, Atmosphere, CIT, Overalls, Aviation, Aircraft, OPOS, Recovery, Transport, HIPAA, Dentistry, Nursing

BALTIMORE, April 18, 2023 (GLOBE NEWSWIRE) -- MediGO , a Baltimore-based healthcare supply chain technology company, is helping to digitally transform the organ recovery process with the launch of its new software solution known as Recovery TeamLink™ .

Key Points: 
  • BALTIMORE, April 18, 2023 (GLOBE NEWSWIRE) -- MediGO , a Baltimore-based healthcare supply chain technology company, is helping to digitally transform the organ recovery process with the launch of its new software solution known as Recovery TeamLink™ .
  • The first-of-its-kind solution provides newfound organ recovery event transparency and coordination for transplant centers, organ procurement organizations (OPOs), donor hospitals and transportation partners.
  • After accepting an organ for transplant, a transplant center must dispatch a recovery team to the donor’s location to recover, preserve and transport the organ to its intended recipient.
  • “We designed Recovery TeamLink to benefit teams and individuals at every step of the organ recovery process,” said Scott Plank, co-founder and CEO of MediGO.

Transplant Logistics Leader MediGO Issues Statement Welcoming HRSA Announcement on Organ Procurement and Transplantation Network Modernization Initiative

Retrieved on: 
Thursday, March 30, 2023
HRSA, Elia del Medigo, Health Resources and Services Administration, U.S. Department of Defense Strategy for Operating in Cyberspace, HHS, OPTN, Office of Inspector General, U.S. Department of Health and Human Services, Transplant, OPOS, Organ, Health, Vision 2021, Edison Awards, Dentistry

HRSA has outlined a transformative and holistic approach in its OPTN Modernization Initiative.

Key Points: 
  • HRSA has outlined a transformative and holistic approach in its OPTN Modernization Initiative.
  • We believe that MediGO solutions have a crucial role to play in achieving HRSA’s goals of enhancing data transparency, monitoring, patient care, quality improvement and innovation.
  • Since our founding in 2020, our vision has been to revolutionize and enhance the transplant process to save more lives.
  • HRSA’s OPTN Modernization Initiative identifies the national transplant system’s need for a comprehensive supply chain orchestration solution.

LiveOnNY and MediGO Collaborate to Launch Groundbreaking Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem

Retrieved on: 
Friday, March 24, 2023
OPO, Elia del Medigo, United Network for Organ Sharing, Communication, GPS, Life, Eye, Innovation system, Multimedia, Transplant, Hospital, Patient, Overmyer Network, ANP, Machine learning, RN, UNOS, Growth, City, Edison Awards, Pharmaceutical industry, Online shopping

This unprecedented growth necessitated the need for better ways of effectively moving these lifesaving organs to those in need.

Key Points: 
  • This unprecedented growth necessitated the need for better ways of effectively moving these lifesaving organs to those in need.
  • A total of 48% of 1,300 gifted organs were transported out of the LiveOnNY Federally Designated Service Area in 2022.
  • LiveOnNY is a member of the United Network for Organ Sharing (UNOS), which oversees the organ transplant waiting list in the U.S. For more information, please visit LiveOnNY.org.
  • MediGO 's innovative healthcare supply chain technology digitally orchestrates the U.S. organ donation and transplant system to improve fairness and equity, reduce nonuse of donated organs, and save more lives.

Atropos Health Announces Clinical Advisory Board to Further Deliver its Promise on Bringing Real-World Evidence to Healthcare

Retrieved on: 
Thursday, March 23, 2023
LifePoint Health, Elia del Medigo, Partnership, University, Dorothy, Stanford University, Johns Hopkins University, OMNY, Health, Human, Research, Pediatric Critical Care Medicine, MBA, CMO, Stanford University Medical Center, Atropos, Clinical professor, UNC Health Care, Johns Hopkins School of Medicine, The Advisory Board Company, MUSC Health University Medical Center, Hospital medicine, MD, UCSF, Prisma Health, Physician, Patient, Chief digital officer, Stanford University School of Medicine, DTS, Knowledge, Entrepreneurship, Chief commercial officer, ROI, MPH, Clinical, Pharmaceutical industry, Nursing, Management, Hospital, Medicine

PALO ALTO, Calif., March 23, 2023 /PRNewswire/ -- Atropos Health, the leader in generating personalized real-world evidence at the point and pace of care, today announced a newly formed Clinical Advisory Board consisting of physicians and executives from Stanford Health Care, John Hopkins Medicine, University of North Carolina Health, and more. The Clinical Advisory Board will further Atropos Health's mission of providing health systems and data companies alike with access to rapid, real-world medical evidence and actionable insights.

Key Points: 
  • The Clinical Advisory Board will further Atropos Health's mission of providing health systems and data companies alike with access to rapid, real-world medical evidence and actionable insights.
  • The Clinical Advisory Board consists of ten inaugural members, led by Chair, Dr. Nick Patel.
  • "Atropos Health has transformed healthcare research and delivery by breaking down barriers to data access and creating an observational insights exchange," said Dr. Patel.
  • Atropos Health's Clinical Advisory Board Members:
    Nick Patel MD - Chair of Advisory Board.

MediGO Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023

Retrieved on: 
Tuesday, March 14, 2023
Research, Surgeon, Early stage innovation company, OPO, Editorial, Anesthesiology, Organization, NASA, MrBeast, Elia del Medigo, ITunes, Transplant, Logistics, Dentistry

In addition to the World’s 50 Most Innovative Companies, 540 organizations are recognized across 54 sectors and regions, with MediGO honored in the Logistics category.

Key Points: 
  • In addition to the World’s 50 Most Innovative Companies, 540 organizations are recognized across 54 sectors and regions, with MediGO honored in the Logistics category.
  • The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year.
  • Additionally, Fast Company will host its third annual Most Innovative Companies Summit on April 19 and 20.
  • Fast Company’s Most Innovative Companies issue (March/April 2023) is available online , as well as by app via iTunes, and on newsstands.

MediGO Named as a Finalist in the Prestigious 2023 Edison Awards™

Retrieved on: 
Tuesday, February 14, 2023
Gold, Science, General Motors, Autonomy, Thomas Edison, Edison Awards, OPO, Silver, Aerospace, Genentech, Robotics, Engineering, OPOS, Marketing, Education, Elia del Medigo, Dentistry, Film industry

BALTIMORE, Feb. 14, 2023 (GLOBE NEWSWIRE) -- MediGO , a digital healthcare supply chain technology company focused on improving equity, access and transparency in the organ donation and transplant industry, has been named a finalist in the 2023 Edison Awards .

Key Points: 
  • BALTIMORE, Feb. 14, 2023 (GLOBE NEWSWIRE) -- MediGO , a digital healthcare supply chain technology company focused on improving equity, access and transparency in the organ donation and transplant industry, has been named a finalist in the 2023 Edison Awards .
  • This is the second straight Edison Awards honor for MediGO, which was named the 2022 Gold winner for Autonomous and Unmanned Systems within the Aerospace and Robotics category alongside sister company MissionGO.
  • All nominations are reviewed by the Edison Awards Steering Committee with the final ballot being determined by an independent judging panel.
  • Gold, Silver and Bronze winners will be announced at the Edison Awards Gala on Thursday, April 20, 2023, in Fort Myers, Florida.

MediGO Leadership Selected to Speak at 2023 SXSW Conference to Discuss Innovation in Organ Transplant Supply Chains

Retrieved on: 
Tuesday, January 17, 2023
Aircraft, Transport, SXSW, Ecosystem, Blood, Kidney, Communication, Death, UAS, Conference, OPA, Patient, Transplant, OPOS, Liver, Pancreas, MUSC, Lunar Landing Research Vehicle, OPO, Medtech, CST, Elia del Medigo, Medical school, Dentistry

BALTIMORE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- MediGO , a Baltimore-based healthcare supply chain technology company, is pleased to share that co-founder and CEO Scott Plank will serve as a panel moderator at the 2023 SXSW Conference.

Key Points: 
  • BALTIMORE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- MediGO , a Baltimore-based healthcare supply chain technology company, is pleased to share that co-founder and CEO Scott Plank will serve as a panel moderator at the 2023 SXSW Conference.
  • The session , Innovating Organ Transplant Supply Chains with UAS, will take place on Sunday, March 12, at 10 a.m. CST, as part of the conference’s Health and MedTech track.
  • I am thrilled that SXSW has offered us the opportunity to present a timely discussion at the 2023 conference about the future of transporting organs,” said Plank.
  • To attend the session, Innovating Organ Transplant Supply Chains with UAS, register for the 2023 SXSW Conference here .